Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever

Standard

Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever. / Oestereich, Lisa; Lüdtke, Anja; Ruibal, Paula; Pallasch, Elisa; Kerber, Romy; Rieger, Toni; Wurr, Stephanie; Bockholt, Sabrina; Pérez-Girón, José V; Krasemann, Susanne; Günther, Stephan; Muñoz-Fontela, César.

In: PLOS PATHOG, Vol. 12, No. 5, 05.2016, p. e1005656.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Oestereich, L, Lüdtke, A, Ruibal, P, Pallasch, E, Kerber, R, Rieger, T, Wurr, S, Bockholt, S, Pérez-Girón, JV, Krasemann, S, Günther, S & Muñoz-Fontela, C 2016, 'Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever', PLOS PATHOG, vol. 12, no. 5, pp. e1005656. https://doi.org/10.1371/journal.ppat.1005656

APA

Oestereich, L., Lüdtke, A., Ruibal, P., Pallasch, E., Kerber, R., Rieger, T., Wurr, S., Bockholt, S., Pérez-Girón, J. V., Krasemann, S., Günther, S., & Muñoz-Fontela, C. (2016). Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever. PLOS PATHOG, 12(5), e1005656. https://doi.org/10.1371/journal.ppat.1005656

Vancouver

Oestereich L, Lüdtke A, Ruibal P, Pallasch E, Kerber R, Rieger T et al. Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever. PLOS PATHOG. 2016 May;12(5):e1005656. https://doi.org/10.1371/journal.ppat.1005656

Bibtex

@article{3711cd631cfa49ffa5c53a9d8b5e1b35,
title = "Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever",
abstract = "Lassa fever (LASF) is a highly severe viral syndrome endemic to West African countries. Despite the annual high morbidity and mortality caused by LASF, very little is known about the pathophysiology of the disease. Basic research on LASF has been precluded due to the lack of relevant small animal models that reproduce the human disease. Immunocompetent laboratory mice are resistant to infection with Lassa virus (LASV) and, to date, only immunodeficient mice, or mice expressing human HLA, have shown some degree of susceptibility to experimental infection. Here, transplantation of wild-type bone marrow cells into irradiated type I interferon receptor knockout mice (IFNAR-/-) was used to generate chimeric mice that reproduced important features of severe LASF in humans. This included high lethality, liver damage, vascular leakage and systemic virus dissemination. In addition, this model indicated that T cell-mediated immunopathology was an important component of LASF pathogenesis that was directly correlated with vascular leakage. Our strategy allows easy generation of a suitable small animal model to test new vaccines and antivirals and to dissect the basic components of LASF pathophysiology.",
author = "Lisa Oestereich and Anja L{\"u}dtke and Paula Ruibal and Elisa Pallasch and Romy Kerber and Toni Rieger and Stephanie Wurr and Sabrina Bockholt and P{\'e}rez-Gir{\'o}n, {Jos{\'e} V} and Susanne Krasemann and Stephan G{\"u}nther and C{\'e}sar Mu{\~n}oz-Fontela",
year = "2016",
month = may,
doi = "10.1371/journal.ppat.1005656",
language = "English",
volume = "12",
pages = "e1005656",
journal = "PLOS PATHOG",
issn = "1553-7366",
publisher = "Public Library of Science",
number = "5",

}

RIS

TY - JOUR

T1 - Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever

AU - Oestereich, Lisa

AU - Lüdtke, Anja

AU - Ruibal, Paula

AU - Pallasch, Elisa

AU - Kerber, Romy

AU - Rieger, Toni

AU - Wurr, Stephanie

AU - Bockholt, Sabrina

AU - Pérez-Girón, José V

AU - Krasemann, Susanne

AU - Günther, Stephan

AU - Muñoz-Fontela, César

PY - 2016/5

Y1 - 2016/5

N2 - Lassa fever (LASF) is a highly severe viral syndrome endemic to West African countries. Despite the annual high morbidity and mortality caused by LASF, very little is known about the pathophysiology of the disease. Basic research on LASF has been precluded due to the lack of relevant small animal models that reproduce the human disease. Immunocompetent laboratory mice are resistant to infection with Lassa virus (LASV) and, to date, only immunodeficient mice, or mice expressing human HLA, have shown some degree of susceptibility to experimental infection. Here, transplantation of wild-type bone marrow cells into irradiated type I interferon receptor knockout mice (IFNAR-/-) was used to generate chimeric mice that reproduced important features of severe LASF in humans. This included high lethality, liver damage, vascular leakage and systemic virus dissemination. In addition, this model indicated that T cell-mediated immunopathology was an important component of LASF pathogenesis that was directly correlated with vascular leakage. Our strategy allows easy generation of a suitable small animal model to test new vaccines and antivirals and to dissect the basic components of LASF pathophysiology.

AB - Lassa fever (LASF) is a highly severe viral syndrome endemic to West African countries. Despite the annual high morbidity and mortality caused by LASF, very little is known about the pathophysiology of the disease. Basic research on LASF has been precluded due to the lack of relevant small animal models that reproduce the human disease. Immunocompetent laboratory mice are resistant to infection with Lassa virus (LASV) and, to date, only immunodeficient mice, or mice expressing human HLA, have shown some degree of susceptibility to experimental infection. Here, transplantation of wild-type bone marrow cells into irradiated type I interferon receptor knockout mice (IFNAR-/-) was used to generate chimeric mice that reproduced important features of severe LASF in humans. This included high lethality, liver damage, vascular leakage and systemic virus dissemination. In addition, this model indicated that T cell-mediated immunopathology was an important component of LASF pathogenesis that was directly correlated with vascular leakage. Our strategy allows easy generation of a suitable small animal model to test new vaccines and antivirals and to dissect the basic components of LASF pathophysiology.

U2 - 10.1371/journal.ppat.1005656

DO - 10.1371/journal.ppat.1005656

M3 - SCORING: Journal article

C2 - 27191716

VL - 12

SP - e1005656

JO - PLOS PATHOG

JF - PLOS PATHOG

SN - 1553-7366

IS - 5

ER -